Get started
Author

Fumiya Watanabe

Observed name: Watanabe, Fumiya
ORCID: 0000-0001-5272-2249
Observed ORCID: 0000-0001-5272-2249
OpenAlex ID: A5090937069
Pharmacokinetics and Adverse Effects of Clofazimine in the Treatment of Pulmonary Non-Tuberculous Mycobacterial Infection
2022 · Fumiya Watanabe, Koji Furuuchi, et al. · Antimicrobial Agents and Chemotherapy · 17
Low-dosage ethambutol, less than 12.5 mg/kg/day, does not worsen the clinical outcomes of pulmonary Mycobacterium avium and Mycobacterium intracellulare disease: a retrospective cohort study
2022 · Fumiya Watanabe, Shota Kaburaki, et al. · Infection · 11
Clofazimine serum concentration and safety/efficacy in nontuberculous mycobacterial pulmonary disease treatment
2024 · Fumiya Watanabe, Keiji Fujiwara, et al. · Respiratory Medicine · 9
Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary disease
2023 · Masashi Ito, Koji Furuuchi, et al. · Respiratory Medicine · 7
PDF
Beyond Symptoms: Radiologic identification of asymptomatic Mycobacterium avium complex pulmonary infections
2024 · Keiji Fujiwara, Fumiya Watanabe, et al. · Respiratory Medicine · 6
PDF
Quantifying the Reversibility of Clofazimine-induced Pigmentation in a Patient with Mycobacterium abscessus Pulmonary Disease
2024 · Masashi Ito, Fumiya Watanabe, et al. · Internal Medicine · 5
PDF
Pharmacokinetics of anti-Mycobacterium avium-intracellulare disease drugs in silkworms
2024 · Fumiya Watanabe, Yasuhiko Matsumoto, et al. · Scientific Reports · 5
Concentration-dependent suppression of macrolide resistance in Mycobacterium avium by combination therapy: An improved in vitro time-kill assay and alveolar macrophage exposure-based pharmacokinetic/pharmacodynamic modeling study
2026 · Fumiya Watanabe, Yuta Morishige, et al. · Journal of Infection and Chemotherapy · 4
PDF
Clinical considerations of the safety and efficacy of clofazimine in the treatment of nontuberculous mycobacterial disease
2025 · Fumiya Watanabe · Journal of Infection and Chemotherapy · 4
Amikacin exposure and its association with ototoxicity and efficacy in nontuberculous mycobacterial pulmonary disease treatment
2026 · Fumiya Watanabe, Tatsuya Kodama, et al. · Respiratory Medicine · 3
Risk factors, molecular analysis and treatment outcomes of amikacin-resistant Mycobacterium avium complex pulmonary disease
2025 · Tatsuya Kodama, Akio Aono, et al. · ERJ Open Research · 3
Population Pharmacokinetic Analysis of Vancomycin in Patients with Solid or Hematological Malignancy in Relation to the Quick Sequential Organ Failure Assessment Scores
2023 · Yasumasa Tsuda, Masahiro Takahashi, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 3
Pulmonary pharmacokinetics and lesion penetration of antimicrobials in patients with nontuberculous mycobacterial disease
2026 · Fumiya Watanabe, Miyako Hiramatsu, et al. · Antimicrobial Agents and Chemotherapy · 1
Prediction of hyperkalemia occurrence in patients using co-trimoxazole: Clinical adjustment of a Markov model
2025 · Fumiya Watanabe, Toshinori Hirai, et al. · International Journal of Clinical Pharmacology and Therapeutics · 1
Potential efficacy of Streptomycin in AMK-resistant Mycobacterium avium-intracellulare complex pulmonary disease
2026 · Tatsuya Kodama, Kozo Morimoto, et al. · European Respiratory Journal
Ethambutol resistance preceding macrolide resistance in Mycobacterium avium complex pulmonary disease: a retrospective longitudinal study and in vitro analysis
2026 · Masashi Ito, Fumiya Watanabe, et al. · medRxiv
PDF
Potential Efficacy of Streptomycin in Amikacin-resistant Mycobacterium avium-intracellulare Complex Pulmonary Disease
2026 · Tatsuya Kodama, Kozo Morimoto, et al. · medRxiv
PDF
肺非結核性抗酸菌症患者におけるクロファジミンの薬物動態と安全性・有効性の検討
2025 · 渡辺, 史也, Watanabe, Fumiya · Institutional Repositories DataBase (IRDB)
PDF
Safety and efficacy of clofazimine are correlated with its serum concentration: Findings of a prospective observational study for pulmonary nontuberculous mycobacterial disease
2024 · Fumiya Watanabe, Keiji Fujiwara, et al. · European Respiratory Journal
Correction: Population Pharmacokinetic Analysis of Vancomycin in Patients with Solid or Hematological Malignancy in Relation to the Quick Sequential Organ Failure Assessment Scores
2024 · Yasumasa Tsuda, Masahiro Takahashi, et al. · European Journal of Drug Metabolism and Pharmacokinetics
PDF
Works count: 20
Citation count: 79
H-index: 5
I10-index: 2
Year
Topic
Type